Mitant 25mg (Sunitinib Malate Capsule) 25mg

Mitant 25mg (Sunitinib Malate) is an oral capsule used for cancer treatment support. This 25mg strength medication is prescribed to manage certain tumor types. Store at ambient temperature for stability. Always follow healthcare provider guidance.

Strength

25mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Hetero Labs Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mitant 25mg is used to treat specific types of cancer by slowing tumor growth. It belongs to a class of medications that target cancer cells. Patients often ask what is Sunitinib Malate used for, and it is primarily indicated for gastrointestinal stromal tumors and advanced kidney cancer. The 25mg capsule form provides a standard starting dose.

Side Effects

Mitant 25mg may cause fatigue, nausea, or digestive discomfort as common effects. Some users report changes in taste or skin discoloration. These effects vary by individual and are typically temporary. Monitoring by a healthcare professional is recommended during treatment.

Precautions & Warnings

Keep Mitant 25mg in its original packaging away from moisture and heat. Do not open or crush the capsules unless advised by a doctor. Inform your healthcare provider about all medications and conditions before starting treatment. Regular check-ups help manage potential side effects.

Avoid Interactions

Mitant 25mg may interact with other drugs, including certain antibiotics and antifungals. Grapefruit products can affect how the medication works. Avoid alcohol unless cleared by a doctor. Always disclose all supplements and prescriptions to your healthcare team.

Frequently Asked Questions

Mitant 25mg is used to treat certain cancers by slowing tumor growth. It is prescribed for gastrointestinal stromal tumors and advanced kidney cancer.

Store Mitant 25mg at ambient temperature in a dry place. Keep it in the original packaging to protect from moisture.

Consult your doctor before combining Mitant 25mg with other drugs. Some medications may interact and affect its effectiveness.

Common side effects include fatigue, nausea, and digestive discomfort. Skin changes or taste alterations may also occur.

No, Mitant 25mg requires a prescription from a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.